They engender endothelial dysfunction by inhibiting endothelial NOS and therefore impairing both NO production and its release via apolipoprotein E receptor 2 (apoER2) and protein phosphatase 2A (PP2A) [63]. This evidence concerns the gene LRP8 and endothelial dysfunction.